First-select the target: better choice of adjuvant treatments for breast cancer patients.
作者： Aron Goldhirsch , AS Coates , RD Gelber , JH Glick , B Thürlimann
关键词:
摘要: … risk were based upon nodal status; 2003 added endocrine responsiveness to define both risk and especially treatment choice… responsiveness and modified risk classification. Prognosis …
annalsofoncology.org
oup.com
oxfordjournals.org
elsevier.com
paperity.org参考文章(22)
Marco Colleoni, Shari Gelber, Alan S. Coates, Monica Castiglione-Gertsch, Richard D. Gelber, Karen Price, Carl-Magnus Rudenstam, Jurij Lindtner, John Collins, Beat Thürlimann, Stig B. Holmberg, H. Cortes-Funes, Edda Simoncini, Elizabeth Murray, Martin Fey, Aron Goldhirsch, Influence of Endocrine-Related Factors on Response to Perioperative Chemotherapy for Patients With Node-Negative Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 4141- 4149 ,(2001) , 10.1200/JCO.2001.19.21.4141
Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred, Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 1474- 1474 ,(1999) , 10.1200/JCO.1999.17.5.1474
Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0
Aron Goldhirsch, William C. Wood, Richard D. Gelber, Alan S. Coates, Beat Thürlimann, Hans-Jörg Senn, Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer Journal of Clinical Oncology. ,vol. 21, pp. 3357- 3365 ,(2003) , 10.1200/JCO.2003.04.576
William C. Wood, Marge Anderson, Robert H. Lyles, Toncred M. Styblo, Douglas Murray, Charles Staley, Lily Yang, Grant Carlson, Can We Select Which Patients With Small Breast Cancers Should Receive Adjuvant Chemotherapy? Annals of Surgery. ,vol. 235, pp. 859- 862 ,(2002) , 10.1097/00000658-200206000-00014
Anna M. Bofin, Borgny Ytterhus, Cara Martin, John J. O’Leary, Bjørn M. Hagmar, Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma. American Journal of Clinical Pathology. ,vol. 122, pp. 110- 119 ,(2004) , 10.1309/8A2DJFT07NE6EWHE
José Baselga, Luca Gianni, Charles Geyer, Edith A. Perez, Alessandro Riva, Christian Jackisch, Future options with trastuzumab for primary systemic and adjuvant therapy Seminars in Oncology. ,vol. 31, pp. 51- 57 ,(2004) , 10.1053/J.SEMINONCOL.2004.07.022
Anne Hamilton, Gabriel Hortobagyi, Chemotherapy: What Progress in the Last 5 Years? Journal of Clinical Oncology. ,vol. 23, pp. 1760- 1775 ,(2005) , 10.1200/JCO.2005.10.034
Alan S Coates, Aron Goldhirsch, Richard D Gelber, Overhauling the breast cancer overview: are subsets subversive? Lancet Oncology. ,vol. 3, pp. 525- 526 ,(2002) , 10.1016/S1470-2045(02)00842-2
J. Alexieva-Figusch, F.H. de Jong, S.W.J. Lamberts, H.A. van Gilse, J.G.M. Klijn, Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer European Journal of Cancer and Clinical Oncology. ,vol. 23, pp. 1349- 1356 ,(1987) , 10.1016/0277-5379(87)90119-2